Published Date:2024-09-05 Original Link:https://www.onenessbio.com/en/news_detail316_1.htm No 2 Date of announcement 2024/09/05 Time of announcement 17:58:20 Subject The post hoc analysis of the global novel drug, Fespixon (ON101), on hard-to-heal diabetic foot ulcers has been published in Advances in Wound Care To which item it meets paragraph 53 Date of events 2024/09/05 Statement Date of occurrence of...Read More

Published Date:2024-09-05 Original Link:https://www.onenessbio.com/en/news_detail315_1.htm No 1 Date of announcement 2024/09/05 Time of announcement 15:30:21 Subject The Company’s security trading have reached threshold of mandatory disclosure of financial information per TPEx requirements To which item it meets paragraph 53 Date of events 2024/09/05 Statement Date of occurrence of the event:2024/09/05 Cause of occurrence:Proceeded according to the...Read More